Cargando…

Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease

SIMPLE SUMMARY: Despite their excellent prognosis, pediatric differentiated thyroid cancers (P-DTC) often undergo aggressive treatment due to the advanced disease presentation. Reliable risk stratification tools to guide management are needed; unfortunately, the current American Thyroid Association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sapuppo, Giulia, Hartl, Dana, Fresneau, Brice, Hadoux, Julien, Breuskin, Ingrid, Baudin, Eric, Rigaud, Charlotte, Guerlain, Joanne, Al Ghuzlan, Abir, Leboulleux, Sophie, Schlumberger, Martin, Lamartina, Livia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345030/ https://www.ncbi.nlm.nih.gov/pubmed/34359632 http://dx.doi.org/10.3390/cancers13153732

Ejemplares similares

Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer
por: Hartl, Dana M., et al.
Publicado: (2020)

Pathological Analysis of Encased Resected Recurrent Nerves in Locally Invasive Thyroid Cancer
por: Dahan, Alexandre, et al.
Publicado: (2022)

Strategies for Radioiodine Treatment: What’s New
por: Sparano, Clotilde, et al.
Publicado: (2022)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival
por: Hescot, Segolene, et al.
Publicado: (2022)

Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
por: Jannin, Arnaud, et al.
Publicado: (2022)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
por: Bardet, Stéphane, et al.
Publicado: (2022)

Kinase inhibitors for advanced medullary thyroid carcinoma
por: Schlumberger, Martin, et al.
Publicado: (2012)

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging
por: Pellegriti, G, et al.
Publicado: (2003)

Treatment of distant metastases from follicular cell-derived thyroid cancer
por: Schlumberger, Martin, et al.
Publicado: (2015)

Radiation exposure and thyroid cancer: a review
por: Iglesias, Maria Laura, et al.
Publicado: (2017)

Intraoperative Autofluorescence Imaging for Parathyroid Gland Identification during Total Laryngectomy with Thyroidectomy †
por: Obongo Anga, Raïs, et al.
Publicado: (2023)

Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
por: Caillou, Bernard, et al.
Publicado: (2011)

ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
por: Roux, Charles, et al.
Publicado: (2022)

Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

Advances in Functional Imaging of Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Recent advances in managing differentiated thyroid cancer
por: Lamartina, Livia, et al.
Publicado: (2018)

Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience
por: Touloupas, Caroline, et al.
Publicado: (2021)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
por: Guignat, L, et al.
Publicado: (2001)

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
por: Xu, Bin, et al.
Publicado: (2022)

The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival
por: Sapuppo, Giulia, et al.
Publicado: (2020)

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine
por: Nocera, M, et al.
Publicado: (2000)

DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms †
por: Vielh, Philippe, et al.
Publicado: (2020)

Interobserver agreement of various thyroid imaging reporting and data systems
por: Grani, Giorgio, et al.
Publicado: (2017)

Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
por: Abdelmoumene, N., et al.
Publicado: (1994)

RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
por: Deandreis, Désirée, et al.
Publicado: (2021)

Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial
por: Kiyota, Naomi, et al.
Publicado: (2022)

Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM
por: Sapuppo, Giulia, et al.
Publicado: (2023)

Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
por: Matrone, Antonio, et al.
Publicado: (2020)

Is thyroid nodule location associated with malignancy risk?
por: Ramundo, Valeria, et al.
Publicado: (2019)

Thyroid Incidentalomas: Epidemiology, Risk Stratification with Ultrasound and Workup
por: Russ, Gilles, et al.
Publicado: (2014)

D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
por: Porcelli, Tommaso, et al.
Publicado: (2023)

Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up
por: Rosignolo, Francesca, et al.
Publicado: (2017)

Localization and characterization of thyroid microcalcifications: A histopathological study
por: Guerlain, Joanne, et al.
Publicado: (2019)

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
por: Tavarelli, Martina, et al.
Publicado: (2017)

Deiodinases in thyroid tumorigenesis
por: Angela De Stefano, Maria, et al.
Publicado: (2023)

Non-Marked Hypoechogenic Nodules: Multicenter Study on the Thyroid Malignancy Risk Stratification and Accuracy Based on TIRADS Systems Comparison
por: Prieditis, Peteris, et al.
Publicado: (2022)

Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families
por: Tavarelli, Martina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mujanqvket4nh00km77lm0sf3e